DOH Advisory: Updated Guidance for Invasive Group A Streptococcal (iGAS)

The attached Invasive Group A Streptococcal (iGAS) advisory provides an update to the advisory previously issued on April 7, 2023.

• Provisional surveillance data demonstrate substantially higher incidence of invasive group A streptococcal infections during 2023 compared to pre-pandemic levels.
• Recent laboratory data show decreased antimicrobial susceptibility to both clindamycin and erythromycin.
• Health care providers are asked to raise their index of suspicion for invasive group A streptococcal infections and obtain relevant cultures when clinically indicated.

For questions, please send an e-mail to bcdc@health.ny.gov.

NYSHFA | NYSCAL CONTACTS:

Tarrah Quinlan, RN, BSN
Director of Education Program Development and Member Operations
518-462-4800 x20

Lisa Volk, RN, B.P.S., LNHA
Executive Director, Foundation for Quality Care
518-462-4800 x15